AMRS
Price:
$0.05
Market Cap:
$18.47M
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known...[Read more]
Industry
Chemicals - Specialty
IPO Date
2010-09-28
Stock Exchange
NASDAQ
Ticker
AMRS
According to Amyris, Inc.’s latest financial reports and current stock price. The company's current ROE is 99.27%. This represents a change of 180.40% compared to the average of 35.40% of the last 4 quarters.
The mean historical ROE of Amyris, Inc. over the last ten years is 81.23%. The current 99.27% ROE has changed 22.21% with respect to the historical average. Over the past ten years (40 quarters), AMRS's ROE was at its highest in in the June 2020 quarter at 177.09%. The ROE was at its lowest in in the September 2013 quarter at -2395.94%.
Average
81.23%
Median
103.80%
Minimum
-105.07%
Maximum
188.65%
Discovering the peaks and valleys of Amyris, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 207.41%
Maximum Annual ROE = 188.65%
Minimum Annual Increase = -7606.73%
Minimum Annual ROE = -105.07%
Year | ROE | Change |
---|---|---|
2022 | 110.80% | -205.45% |
2021 | -105.07% | -155.70% |
2020 | 188.65% | 94.88% |
2019 | 96.81% | -19.67% |
2018 | 120.51% | 207.41% |
2017 | 39.20% | -23.94% |
2016 | 51.54% | -62.62% |
2015 | 137.89% | -7606.73% |
2014 | -1.84% | -101.06% |
2013 | 173.82% | -156.86% |
The current ROE of Amyris, Inc. (AMRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
64.79%
5-year avg
82.34%
10-year avg
81.23%
Amyris, Inc.’s ROE is less than Aemetis, Inc. (21.44%), greater than Codexis, Inc. (-95.80%), greater than Gevo, Inc. (-13.50%), greater than GrowGeneration Corp. (-28.45%), greater than Pacific Biosciences of California, Inc. (-61.44%),
Company | ROE | Market cap |
---|---|---|
21.44% | $104.30M | |
-95.80% | $194.34M | |
-13.50% | $174.00M | |
-28.45% | $110.06M | |
-61.44% | $430.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amyris, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Amyris, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Amyris, Inc.'s ROE?
How is the ROE calculated for Amyris, Inc. (AMRS)?
What is the highest ROE for Amyris, Inc. (AMRS)?
What is the 3-year average ROE for Amyris, Inc. (AMRS)?
What is the 5-year average ROE for Amyris, Inc. (AMRS)?
How does the current ROE for Amyris, Inc. (AMRS) compare to its historical average?